Lumos Diagnostics Holdings Limited
LDXHF
$0.16
$0.00-0.93%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.06M | 3.06M | 3.05M | 3.05M | 3.15M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.06M | 3.06M | 3.05M | 3.05M | 3.15M |
| Cost of Revenue | 983.50K | 983.50K | 1.33M | 1.33M | 1.03M |
| Gross Profit | 2.08M | 2.08M | 1.72M | 1.72M | 2.12M |
| SG&A Expenses | 4.58M | 4.58M | 3.41M | 3.41M | 3.15M |
| Depreciation & Amortization | 636.00K | 636.00K | 592.00K | 592.00K | 672.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.32M | 6.32M | 5.35M | 5.35M | 4.89M |
| Operating Income | -3.26M | -3.26M | -2.30M | -2.30M | -1.73M |
| Income Before Tax | -2.44M | -2.44M | -2.19M | -2.19M | -1.40M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.44M | -2.44M | -2.19M | -2.19M | -1.40M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.44M | -2.44M | -2.19M | -2.19M | -1.40M |
| EBIT | -3.26M | -3.26M | -2.30M | -2.30M | -1.73M |
| EBITDA | -2.62M | -2.62M | -2.15M | -1.98M | -1.06M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 772.44M | 772.44M | 747.41M | 747.41M | 612.96M |
| Average Diluted Shares Outstanding | 772.44M | 772.44M | 747.41M | 747.41M | 612.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |